当前位置: 首页 > 期刊 > 《中国性科学》 > 2010年第10期
编号:11964845
血清VEGF\CA-125与β-HCG在异位妊娠治疗中的价值(2)
http://www.100md.com 2010年10月1日 《中国性科学》 2010年第10期
     参考文献

    1 Cracia CR,Barnhart KT.Diagnosing ectopic pregnancy:decision analysis compared six strategies[J].Obstet Gynecol,2001,97(3):464-470.

    2 Elson J,Tailor A,Banerjee,et al. Expectant management of tubal ectopic pregnancy:prediction of successful outcome using decision tree analysis[J].Ultrasound Obstet Gynecol,2006,23(6):552-556.

    3 Condous G,Kirk E,Syed A,et al.Do levels of serum cancer antigen 125 and creatine kinase predict the outcome in pregnancies of unknown location[J].Hum Reprod,2005,20(12):3348-3354.

    4 Malatyalioglu E,Ozer S,Kokcu A,et al.CA-125 levels in ruptured and unruptured tubal ectopic pregnancies [J].J Obstet Gynaecol Res,2006,32(4):422-427.

    5 Krussel JS,Behr B,Milki AA,et al.Vascular endothelial growth factor(VEGF)mRNA spilce variants are differentially expressed in human blastocysts[J]. Mol Hum Reprod,2001,7(1):57-63.

    6 Felemban A,Sammour A,Tulandi T.Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy[J]. Hum Reprod,2002,17(2):490-492.

    [收稿日期:2010-07-09], 百拇医药(郝玉凤 王 茜 王 鲲 李金业 李 阳 韩思阳)
上一页1 2